More than 150 clinical trials are open at Providence Cancer Center
October 2017
Providence Cancer Center is currently conducting more than 150 research studies, including clinical trials of targeted therapies and novel immunotherapy approaches. Please see the links below for studies in specific disease areas.
Phase I trials offer new treatment approaches
Phase I studies are the foundation for advancing cancer treatment with new agents and combinations of therapies. Providence Cancer Center offers phase I studies for multiple cancer types, including these:
